多重器官衰竭:修订间差异

维基百科,自由的百科全书
删除的内容 添加的内容
It's gonna be awesome留言 | 贡献
无编辑摘要
It's gonna be awesome留言 | 贡献
无编辑摘要
第1行: 第1行:
{{expert|time=2013-08-05T07:30:41+00:00}}
{{expert|time=2013-08-05T07:30:41+00:00}}
{{Translating|||time=2017-05-17T17:28:44+00:00}}
{{medref}}
{{medical}}
{{medical}}
{{Infobox disease
{{Infobox disease
| Name = 多重器官衰竭
| Name = 多重器官衰竭(Multiple organ dysfunction syndrome )
| Image =
| Image =
| Caption =
| Caption =
第17行: 第17行:
}}
}}
'''器官衰竭''',或稱'''多重器官衰竭'''('''Multiple organ dysfunction syndrome''', '''MODS''')、'''多器官衰竭'''、'''多臟器功能衰竭''',是[[老年人]][[逝世]]的重要原因之一,大多是70歲以上的[[長者]]。例如有[[氣管]]、[[心臟]]、[[肺臟]]、[[肝臟]]、[[腎臟]]、[[腦]]等重要[[身體]][[器官]]的[[慢性病]]。
'''器官衰竭''',或稱'''多重器官衰竭'''('''Multiple organ dysfunction syndrome''', '''MODS''')、'''多器官衰竭'''、'''多臟器功能衰竭''',是[[老年人]][[逝世]]的重要原因之一,大多是70歲以上的[[長者]]。例如有[[氣管]]、[[心臟]]、[[肺臟]]、[[肝臟]]、[[腎臟]]、[[腦]]等重要[[身體]][[器官]]的[[慢性病]]。

'''Multiple organ dysfunction syndrome''' ('''MODS'''), also known as '''multiple organ failure''' ('''MOF'''), '''total organ failure''' ('''TOF''') or '''multisystem organ failure''' ('''MSOF'''), is altered [[organ (anatomy)|organ]] function in an acutely ill patient requiring [[medicine|medical]] intervention to achieve [[homeostasis]].

Although Irwin-Rippe cautions in 2005 that the use of "multiple organ failure" or "multisystem organ failure" should be avoided,<ref name="Irwin-Rippe">{{cite book|url=http://www.lww.com/product/?0-7817-3548-3|title= Intensive Care Medicine|author=Irwin|author2=Rippe|last-author-amp=yes |archivedate=November 7, 2005|deadurl=yes|archiveurl=https://web.archive.org/web/20051107202505/http://www.lww.com/product/?0-7817-3548-3}}</ref> both Harrison's (2015) and Cecil's (2012) medical textbooks still use the terms "multi-organ failure" and "multiple organ failure" in several chapters, and do not use "multiple organ dysfunction syndrome" at all.

==Definition==
Multiple organ dysfunction syndrome is the presence of altered organ function in acutely ill patients such that [[homeostasis]] cannot be maintained without intervention. It usually involves two or more organ systems.<ref name="Irwin-Rippe"/>


==[[併發症]]==
==[[併發症]]==
多器官衰竭時,可能[[呼吸]]短淺、[[血壓]]急降、[[唇|口唇]]和[[指甲]]缺氧變[[紫色]]、[[視覺]][[神經]]無反應、[[意識]]朦朧、[[血液]]缺[[氧]]、[[休克]]、[[昏迷]]等。
多器官衰竭時,可能[[呼吸]]短淺、[[血壓]]急降、[[唇|口唇]]和[[指甲]]缺氧變[[紫色]]、[[視覺]][[神經]]無反應、[[意識]]朦朧、[[血液]]缺[[氧]]、[[休克]]、[[昏迷]]等。


==Cause==
The condition usually results from infection, injury (accident, surgery), [[hypoperfusion]] and [[hypermetabolism]]. The primary cause triggers an uncontrolled [[inflammation|inflammatory response]]. [[Sepsis]] is the most common cause.
Sepsis may result in [[septic shock]]. In the absence of infection, a sepsis-like disorder is termed [[systemic inflammatory response syndrome]] (SIRS). Both SIRS and sepsis could ultimately progress to multiple organ dysfunction syndrome. However, in one-third of the patients no primary focus can be found.<ref name="Irwin-Rippe"/> Multiple organ dysfunction syndrome is well established as the final stage of a continuum: [[systemic inflammatory response syndrome|SIRS]] + infection [[File:U+2192.svg]] sepsis [[File:U+2192.svg]] severe sepsis [[File:U+2192.svg]] Multiple organ dysfunction syndrome. Currently, investigators are looking into genetic targets for possible gene therapy to prevent the progression to Multiple organ dysfunction syndrome. Some authors have conjectured that the inactivation of the transcription factors [[NF-κB]] and [[AP-1 (transcription factor)|AP-1]] would be appropriate targets in preventing sepsis and [[systemic inflammatory response syndrome|SIRS]].<ref>{{cite journal |vauthors=Matsuda N, Hattori Y |title=Systemic inflammatory response syndrome (SIRS): molecular pathophysiology and gene therapy |journal=J. Pharmacol. Sci. |volume=101 |issue=3 |pages=189–98 |year=2006 |pmid=16823257 |doi=10.1254/jphs.CRJ06010X}}</ref> These two [[genes]] are pro-inflammatory. However, they are essential components of a normal healthy [[immune response]], so there is risk of increasing vulnerability to infection, which can also cause clinical deterioration.

Some have developed a [[mouse]] model sepsis via [[cecal]] [[Ligature (medicine)|ligation]] and puncture (CLP).<ref>{{cite journal |vauthors=Kabay B, Kocaefe C, Baykal A, etal |title=Interleukin-10 gene transfer: prevention of multiple organ injury in a murine cecal ligation and puncture model of sepsis |journal=World J Surg |volume=31 |issue=1 |pages=105–15 |year=2007 |pmid=17171483 |doi=10.1007/s00268-006-0066-9}}</ref> Male [[Balb/c]] mice subjected to CLP were given an [[Interleukin 10|IL-10]]-carrying vector or an empty control vector. [[Lung]], [[Liver]] and [[kidney]] tissue destruction were measured by assessing [[myeloperoxidase]] and malonialdehyde activity; these last two are endogenous oxidizing compounds produced during tissue [[inflammation]]. The authors assessed the level [[neutrophil]] infiltration in lung and liver tissue. [[Interleukin 10|IL-10]] protein expression was measured using immunohistochemistry. The expression of [[Tumor necrosis factor-alpha]] (TNF-α) [[mRNA]] was measured at 3, 8 and 24 hours after CLP using [[reverse transcription polymerase chain reaction]]. Their results show significantly reduced organ damage by [[Interleukin 10|IL-10]] gene transfer, as quantified by reduced [[myeloperoxidase]] activity in the [[lung]], [[liver]] and [[kidney]]. The malonialdehyde level was not affected by the transfer into the [[liver]]. The livers of the mice infected with the adenoviral vector showed reduced [[neutrophil]] activity. The [[lung]] and [[kidney]] samples in mice carrying the gene showed lower expression of [[Tumor necrosis factor-alpha|TNF-α]] [[mRNA]]. The investigators concluded that increased [[Interleukin 10|IL-10]] expression significantly reduced [[sepsis]]-induced Multiple organ injury.


==Pathophysiology==
A definite explanation has not been found. Local and systemic responses are initiated by tissue damage. [[Respiratory failure]] is common in the first 72 hours after the original insult. Subsequently, one might see [[liver failure]] (5–7 days), [[gastrointestinal bleeding]] (10–15 days) and [[kidney failure]] (11–17 days).<ref name="Irwin-Rippe"/>

===Gut hypothesis===
The most popular hypothesis by Deitch to explain MODS in critically ill patients is the gut hypothesis.<ref>Deitch EA. Simple intestinal obstruction causes bacterial translocation in man. ''[[Arch Surg]]'' 1989; '''124''': 699-701. PMID 2730322</ref> Due to [[splanchnic]] [[hypoperfusion]] and the subsequent mucosal ischaemia there are structural changes and alterations in cellular function. This results in increased [[gut permeability]], changed immune function of the gut and increased translocation of [[bacteria]]. Liver dysfunction leads to toxins escaping into the systemic circulation and activating an immune response. This results in tissue injury and organ dysfunction.<ref name="Irwin-Rippe"/>

===Endotoxin macrophage hypothesis===
[[Gram-negative]] infections in MODS patients are relatively common, hence [[endotoxin]]s have been advanced as principal mediator in this disorder. It is thought that following the initial event [[cytokine]]s are produced and released. The pro-inflammatory mediators are: [[tumor necrosis factor-alpha]] (TNF-α), [[interleukin]]-1, interleukin-6, [[thromboxane]] A2, [[prostacyclin]], platelet activating factor, and [[nitric oxide]].<ref name="Irwin-Rippe"/>

===Tissue hypoxia-microvascular hypothesis===
As a result of macro- and microvascular changes insufficient supply of oxygen occurs. [[Hypoxia (medical)|Hypoxemia]] causes cell death and organ dysfunction.<ref name="Irwin-Rippe"/>

===Mitochondrial DNA hypothesis===
According to findings of Professor Zsolt Balohh and his team at [[University of Newcastle (Australia)]], [[mitochondrial DNA]] is the leading cause of severe inflammation due to massive amount of Mitochondrial DNA that leaks into the blood stream due to [[cell death]] into the blood stream of patients that survived [[major trauma]].

Mitochondrial DNA is very similar-looking like bacterial DNA. And if bacteria is triggering leukocytes, maybe the mitochondrial DNA does the same. When confronted with bacteria, white blood cells, or [[neutrophil granulocyte]], behave like predatory spiders. They spit out a web, or net, to trap the invaders, then hit them with a deadly oxidative blast, forming [[neutrophil extracellular traps]] (NETs).

This result in catastrophic immune response leading to multiple organ dysfunction syndrome.<ref name="Mitochondrial DNA hypothesis">{{cite journal|pmid=25128442|title=Mitochondrial DNA neutrophil extracellular traps are formed after trauma and subsequent surgery|doi=10.1016/j.jcrc.2014.07.013|author=McIlroy DJ|displayauthors=etal|journal=Journal of Critical Care|year=2014 |volume=29|issue=6|page=1133}}</ref><ref name="MULTIPLE ORGAN FAILURE ABC Australia">{{cite web|url=http://www.abc.net.au/catalyst/stories/4060404.htm|title=MULTIPLE ORGAN FAILURE|work=ABC Australia|date=7 August 2014}}</ref>

===Integrated hypothesis===
Since in most cases no primary cause is found, the condition could be part of a compromised homeostasis involving the previous mechanisms.<ref name="Irwin-Rippe"/>

==Diagnosis==
The European Society of Intensive Care organized a consensus meeting in 1994 to create the "Sepsis-Related Organ Failure Assessment (SOFA)" score to describe and quantitate the degree of organ dysfunction in six organ systems. Using similar physiologic variables the Multiple Organ Dysfunction Score was developed.<ref name="Irwin-Rippe"/>

Four clinical phases have been suggested:
*'''Stage 1''' the patient has increased volume requirements and mild respiratory [[alkalosis]] which is accompanied by [[oliguria]], [[hyperglycemia]] and increased [[insulin]] requirements.
*'''Stage 2''' the patient is [[tachypneic]], [[hypocapnia|hypocapnic]] and [[hypoxemia|hypoxemic]]; develops moderate [[liver dysfunction]] and possible hematologic abnormalities.
*'''Stage 3''' the patient develops shock with [[azotemia]] and [[acid-base]] disturbances; has significant [[coagulation]] abnormalities.
*'''Stage 4''' the patient is [[vasopressor]] dependent and [[oliguric]] or [[anuric]]; subsequently develops [[ischemic colitis]] and [[lactic acidosis]].

==Management==
At present there is no agent that can reverse the established organ failure. Therapy therefore is limited to supportive care, i.e. safeguarding hemodynamics, and respiration. Maintaining adequate tissue oxygenation is a principal target. Starting enteral nutrition within 36 hours of admission to an [[intensive care unit]] has reduced infectious complications.<ref name="Irwin-Rippe"/>

==Prognosis==
Mortality varies from 30% to 100% where the chance of survival is diminished as the number of organs involved increases. Since the 1980s the mortality rate has not changed.<ref name="Irwin-Rippe"/> In patients with [[sepsis]], [[septic shock]], or multiple organ dysfunction syndrome that is due to major [[trauma (medicine)|trauma]], the [[rs1800625]] polymorphism is a functional [[single nucleotide polymorphism]], a part of the [[receptor for advanced glycation end products]] (RAGE) [[transmembrane receptor]] gene (of the [[immunoglobulin superfamily]]) and confers [[Host (biology)|host]] susceptibility to sepsis and MODS in these patients.<ref>{{cite journal|url=http://ccforum.com/content/19/1/6/abstract|title=Rs1800625 in the receptor for advanced glycation end products gene predisposes to sepsis and multiple organ dysfunction syndrome in patients with major trauma|author1=Zeng, Ling|displayauthors=etal|doi=10.1186/s13054-014-0727-2|year=2015|journal=Critical Care|volume=19|issue=6|pmid=25572180|pmc=4310192}}</ref>

==History==
The historical origin of the concept of MODS is as follows. For many years, some patients were loosely classified as having ''sepsis'' or the ''sepsis syndrome''. In more recent years, these concepts have been refined – so that there are specific definitions of sepsis – and two new concepts have been developed: the [[systemic inflammatory response syndrome|SIRS]] and MODS.<ref name="Irwin-Rippe"/>

==References==
{{Reflist}}

==Further reading==
* [http://www.lww.com/product/?0-683-05565-8 The ICU Book by Marino]
* [http://www.cecilmedicine.com/buy.cfm?book=goldman Cecil Textbook of Medicine]
* [http://www.oup.com/us/catalog/general/subject/Medicine/PrimaryCare/?ci=0192629220&view=usa The Oxford Textbook of Medicine]
* [http://books.mcgraw-hill.com/medical/harrisons/ Harrison's Principles of Internal Medicine]

{{Intensive care medicine}}
{{Organ failure}}
{{Organ failure}}
{{医学小作品}}


[[Category:器官衰竭| ]]
[[Category:Intensive care medicine]]
[[Category:Organ failure]]
[[Category:Causes of death]]
[[Category:Medical emergencies]]
[[Category:Sepsis]]
[[Category:Syndromes]]

2017年5月17日 (三) 17:28的版本

多重器官衰竭(Multiple organ dysfunction syndrome )
类型器官功能障碍[*]general symptom[*]
分类和外部资源
ICD-11MH16
ICD-9-CM995.92
eMedicinemed/3372
MeSHD009102
[编辑此条目的维基数据]

器官衰竭,或稱多重器官衰竭Multiple organ dysfunction syndrome, MODS)、多器官衰竭多臟器功能衰竭,是老年人逝世的重要原因之一,大多是70歲以上的長者。例如有氣管心臟肺臟肝臟腎臟等重要身體器官慢性病

Multiple organ dysfunction syndrome (MODS), also known as multiple organ failure (MOF), total organ failure (TOF) or multisystem organ failure (MSOF), is altered organ function in an acutely ill patient requiring medical intervention to achieve homeostasis.

Although Irwin-Rippe cautions in 2005 that the use of "multiple organ failure" or "multisystem organ failure" should be avoided,[1] both Harrison's (2015) and Cecil's (2012) medical textbooks still use the terms "multi-organ failure" and "multiple organ failure" in several chapters, and do not use "multiple organ dysfunction syndrome" at all.

Definition

Multiple organ dysfunction syndrome is the presence of altered organ function in acutely ill patients such that homeostasis cannot be maintained without intervention. It usually involves two or more organ systems.[1]

併發症

多器官衰竭時,可能呼吸短淺、血壓急降、口唇指甲缺氧變紫色視覺神經無反應、意識朦朧、血液休克昏迷等。

Cause

The condition usually results from infection, injury (accident, surgery), hypoperfusion and hypermetabolism. The primary cause triggers an uncontrolled inflammatory response. Sepsis is the most common cause. Sepsis may result in septic shock. In the absence of infection, a sepsis-like disorder is termed systemic inflammatory response syndrome (SIRS). Both SIRS and sepsis could ultimately progress to multiple organ dysfunction syndrome. However, in one-third of the patients no primary focus can be found.[1] Multiple organ dysfunction syndrome is well established as the final stage of a continuum: SIRS + infection sepsis severe sepsis Multiple organ dysfunction syndrome. Currently, investigators are looking into genetic targets for possible gene therapy to prevent the progression to Multiple organ dysfunction syndrome. Some authors have conjectured that the inactivation of the transcription factors NF-κB and AP-1 would be appropriate targets in preventing sepsis and SIRS.[2] These two genes are pro-inflammatory. However, they are essential components of a normal healthy immune response, so there is risk of increasing vulnerability to infection, which can also cause clinical deterioration.

Some have developed a mouse model sepsis via cecal ligation and puncture (CLP).[3] Male Balb/c mice subjected to CLP were given an IL-10-carrying vector or an empty control vector. Lung, Liver and kidney tissue destruction were measured by assessing myeloperoxidase and malonialdehyde activity; these last two are endogenous oxidizing compounds produced during tissue inflammation. The authors assessed the level neutrophil infiltration in lung and liver tissue. IL-10 protein expression was measured using immunohistochemistry. The expression of Tumor necrosis factor-alpha (TNF-α) mRNA was measured at 3, 8 and 24 hours after CLP using reverse transcription polymerase chain reaction. Their results show significantly reduced organ damage by IL-10 gene transfer, as quantified by reduced myeloperoxidase activity in the lung, liver and kidney. The malonialdehyde level was not affected by the transfer into the liver. The livers of the mice infected with the adenoviral vector showed reduced neutrophil activity. The lung and kidney samples in mice carrying the gene showed lower expression of TNF-α mRNA. The investigators concluded that increased IL-10 expression significantly reduced sepsis-induced Multiple organ injury.


Pathophysiology

A definite explanation has not been found. Local and systemic responses are initiated by tissue damage. Respiratory failure is common in the first 72 hours after the original insult. Subsequently, one might see liver failure (5–7 days), gastrointestinal bleeding (10–15 days) and kidney failure (11–17 days).[1]

Gut hypothesis

The most popular hypothesis by Deitch to explain MODS in critically ill patients is the gut hypothesis.[4] Due to splanchnic hypoperfusion and the subsequent mucosal ischaemia there are structural changes and alterations in cellular function. This results in increased gut permeability, changed immune function of the gut and increased translocation of bacteria. Liver dysfunction leads to toxins escaping into the systemic circulation and activating an immune response. This results in tissue injury and organ dysfunction.[1]

Endotoxin macrophage hypothesis

Gram-negative infections in MODS patients are relatively common, hence endotoxins have been advanced as principal mediator in this disorder. It is thought that following the initial event cytokines are produced and released. The pro-inflammatory mediators are: tumor necrosis factor-alpha (TNF-α), interleukin-1, interleukin-6, thromboxane A2, prostacyclin, platelet activating factor, and nitric oxide.[1]

Tissue hypoxia-microvascular hypothesis

As a result of macro- and microvascular changes insufficient supply of oxygen occurs. Hypoxemia causes cell death and organ dysfunction.[1]

Mitochondrial DNA hypothesis

According to findings of Professor Zsolt Balohh and his team at University of Newcastle (Australia), mitochondrial DNA is the leading cause of severe inflammation due to massive amount of Mitochondrial DNA that leaks into the blood stream due to cell death into the blood stream of patients that survived major trauma.

Mitochondrial DNA is very similar-looking like bacterial DNA. And if bacteria is triggering leukocytes, maybe the mitochondrial DNA does the same. When confronted with bacteria, white blood cells, or neutrophil granulocyte, behave like predatory spiders. They spit out a web, or net, to trap the invaders, then hit them with a deadly oxidative blast, forming neutrophil extracellular traps (NETs).

This result in catastrophic immune response leading to multiple organ dysfunction syndrome.[5][6]

Integrated hypothesis

Since in most cases no primary cause is found, the condition could be part of a compromised homeostasis involving the previous mechanisms.[1]

Diagnosis

The European Society of Intensive Care organized a consensus meeting in 1994 to create the "Sepsis-Related Organ Failure Assessment (SOFA)" score to describe and quantitate the degree of organ dysfunction in six organ systems. Using similar physiologic variables the Multiple Organ Dysfunction Score was developed.[1]

Four clinical phases have been suggested:

Management

At present there is no agent that can reverse the established organ failure. Therapy therefore is limited to supportive care, i.e. safeguarding hemodynamics, and respiration. Maintaining adequate tissue oxygenation is a principal target. Starting enteral nutrition within 36 hours of admission to an intensive care unit has reduced infectious complications.[1]

Prognosis

Mortality varies from 30% to 100% where the chance of survival is diminished as the number of organs involved increases. Since the 1980s the mortality rate has not changed.[1] In patients with sepsis, septic shock, or multiple organ dysfunction syndrome that is due to major trauma, the rs1800625 polymorphism is a functional single nucleotide polymorphism, a part of the receptor for advanced glycation end products (RAGE) transmembrane receptor gene (of the immunoglobulin superfamily) and confers host susceptibility to sepsis and MODS in these patients.[7]

History

The historical origin of the concept of MODS is as follows. For many years, some patients were loosely classified as having sepsis or the sepsis syndrome. In more recent years, these concepts have been refined – so that there are specific definitions of sepsis – and two new concepts have been developed: the SIRS and MODS.[1]

References

  1. ^ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 Irwin & Rippe. Intensive Care Medicine. (原始内容存档于November 7, 2005). 
  2. ^ Matsuda N, Hattori Y. Systemic inflammatory response syndrome (SIRS): molecular pathophysiology and gene therapy. J. Pharmacol. Sci. 2006, 101 (3): 189–98. PMID 16823257. doi:10.1254/jphs.CRJ06010X. 
  3. ^ Kabay B, Kocaefe C, Baykal A, et al. Interleukin-10 gene transfer: prevention of multiple organ injury in a murine cecal ligation and puncture model of sepsis. World J Surg. 2007, 31 (1): 105–15. PMID 17171483. doi:10.1007/s00268-006-0066-9. 
  4. ^ Deitch EA. Simple intestinal obstruction causes bacterial translocation in man. Arch Surg 1989; 124: 699-701. PMID 2730322
  5. ^ McIlroy DJ; et al. Mitochondrial DNA neutrophil extracellular traps are formed after trauma and subsequent surgery. Journal of Critical Care. 2014, 29 (6): 1133. PMID 25128442. doi:10.1016/j.jcrc.2014.07.013. 
  6. ^ MULTIPLE ORGAN FAILURE. ABC Australia. 7 August 2014. 
  7. ^ Zeng, Ling; et al. Rs1800625 in the receptor for advanced glycation end products gene predisposes to sepsis and multiple organ dysfunction syndrome in patients with major trauma. Critical Care. 2015, 19 (6). PMC 4310192可免费查阅. PMID 25572180. doi:10.1186/s13054-014-0727-2. 

Further reading